FRIDAY, Sept. 17, 2021 (HealthDay News) — Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday. The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or aboveContinue Reading

Here are some of HealthDay’s top stories for Friday, Sept. 17: FDA advisory panel meets on need for COVID-19 booster shots. Presented with evidence seemingly pro and con, an advisory committee to the U.S. Food and Drug Administration will convene Friday to decide whether or not Pfizer-BioNTech vaccine booster shotsContinue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — Childhood obesity was a worrisome issue before the pandemic, and now it’s alarmingly worse, new data shows. A U.S. Centers for Disease Control and Prevention study found a “profound increase in weight gain for kids” that is “substantial and alarming,” Dr. Alyson Goodman,Continue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — Treating sickle cell anemia with the drug hydroxyurea may also reverse related heart abnormalities, a new study suggests. Heart issues are common among people with sickle cell disease. Among them are enlargement of the heart and an impaired ability to relax heart muscles,Continue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — When the COVID-19 public health emergency ends, a new crisis in insurance coverage in the United States may begin. Fifteen million Americans who enrolled in Medicaid during the pandemic could lose their coverage when the emergency declaration ends, according to an analysis byContinue Reading